{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T06:15:29Z","timestamp":1786774529095,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00192-022-05127-3","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T21:08:19Z","timestamp":1646255299000},"page":"1157-1164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The gut, vaginal, and urine microbiome in overactive bladder: a systematic review"],"prefix":"10.1007","volume":"33","author":[{"given":"Christina","family":"Sze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariel","family":"Pressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Richard","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0515-2578","authenticated-orcid":false,"given":"Bilal","family":"Chughtai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"issue":"4 Suppl","key":"5127_CR1","first-page":"S90","volume":"15","author":"E Onukwugha","year":"2009","unstructured":"Onukwugha E, Zuckerman IH, McNally D, et al. The total economic burden of overactive bladder in the United States: a disease-specific approach. Am J Manag Care. 2009;15(4 Suppl):S90\u20137.","journal-title":"Am J Manag Care"},{"key":"5127_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/bju.15040","volume":"126","author":"B Welk","year":"2020","unstructured":"Welk B, McArthur E. Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study. BJU Int. 2020;126:183.","journal-title":"BJU Int"},{"key":"5127_CR3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41585-021-00504-x","volume":"18","author":"B Welk","year":"2021","unstructured":"Welk B, Richardson K, Panicker JN. The cognitive effect of anticholinergics for patients with overactive bladder. Nat Rev Urol. 2021;18:686\u2013700.","journal-title":"Nat Rev Urol"},{"key":"5127_CR4","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","volume":"75","author":"B Peyronnet","year":"2019","unstructured":"Peyronnet B, Mironska E, Chapple C, et al. A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur Urol. 2019;75:988.","journal-title":"Eur Urol"},{"key":"5127_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1128\/JCM.02876-13","volume":"52","author":"EE Hilt","year":"2014","unstructured":"Hilt EE, Mckinley K, Pearce MM, et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol. 2014;52:871.","journal-title":"J Clin Microbiol"},{"key":"5127_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejogrb.2017.04.040","volume":"214","author":"N Curtiss","year":"2017","unstructured":"Curtiss N, Balachandran A, Krska L, et al. A case controlled study examining the bladder microbiome in women with overactive bladder (OAB) and healthy controls. Eur J Obstet Gynecol Reprod Biol. 2017;214:31.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"5127_CR7","doi-asserted-by":"publisher","first-page":"8635","DOI":"10.1038\/srep08635","volume":"5","author":"WZ Ouma","year":"2015","unstructured":"Ouma WZ, Mejia-Guerra MK, Yilmaz A, et al. Important biological information uncovered in previously unaligned reads from chromatin immunoprecipitation experiments (ChIP-Seq). Sci Rep. 2015;5:8635.","journal-title":"Sci Rep"},{"key":"5127_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fcimb.2017.00488","volume":"7","author":"P Wu","year":"2017","unstructured":"Wu P, Chen Y, Zhao J, et al. Urinary microbiome and psychological factors in women with overactive bladder. Front Cell Infect Microbiol. 2017;7:488.","journal-title":"Front Cell Infect Microbiol"},{"key":"5127_CR9","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00192-018-3558-x","volume":"29","author":"K Gill","year":"2018","unstructured":"Gill K, Kang R, Sathiananthamoorthy S, et al. A blinded observational cohort study of the microbiological ecology associated with pyuria and overactive bladder symptoms. Int Urogynecol J. 2018;29:1493.","journal-title":"Int Urogynecol J"},{"key":"5127_CR10","doi-asserted-by":"publisher","first-page":"1805281","DOI":"10.1080\/19490976.2020.1805281","volume":"12","author":"M Magruder","year":"2020","unstructured":"Magruder M, Edusei E, Zhang L, et al. Gut commensal microbiota and decreased risk for Enterobacteriaceae bacteriuria and urinary tract infection. Gut Microbes. 2020;12:1805281.","journal-title":"Gut Microbes"},{"key":"5127_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00345-020-03243-7","volume":"39","author":"T Okamoto","year":"2021","unstructured":"Okamoto T, Hatakeyama S, Imai A, et al. Altered gut microbiome associated with overactive bladder and daily urinary urgency. World J Urol. 2021;39:847.","journal-title":"World J Urol"},{"key":"5127_CR12","doi-asserted-by":"publisher","first-page":"e01283","DOI":"10.1128\/mBio.01283-14","volume":"5","author":"MM Pearce","year":"2014","unstructured":"Pearce MM, Hilt EE, Rosenfeld AB, et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio. 2014;5:e01283.","journal-title":"mBio"},{"key":"5127_CR13","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/s41598-021-81790-8","volume":"11","author":"N Ammitzboll","year":"2021","unstructured":"Ammitzboll N, Bau BPJ, Bundgaard-Nielsen C, et al. Pre- and postmenopausal women have different core urinary microbiota. Sci Rep. 2021;11:2212.","journal-title":"Sci Rep"},{"key":"5127_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/1471-0528.15920","volume":"127","author":"TK Price","year":"2020","unstructured":"Price TK, Hilt EE, Thomas-White K, et al. The urobiome of continent adult women: a cross-sectional study. BJOG. 2020;127:193.","journal-title":"BJOG"},{"key":"5127_CR15","first-page":"e398","volume":"197","author":"J Cohn","year":"2017","unstructured":"Cohn J, Brown ET, Guo Y, et al. MP31-03 the relationship between the urinary microbiome and central sensitization in women with overactive bladder. J Urol. 2017;197:e398.","journal-title":"J Urol"},{"key":"5127_CR16","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, et al. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28:203.","journal-title":"Ann Gastroenterol"},{"key":"5127_CR17","first-page":"e1097","volume":"197","author":"AL Ackerman","year":"2017","unstructured":"Ackerman AL, Tang J, Eilber K, et al. MP82-02 decreased urinary fungal burden and diversity in overactive bladder. J Urol. 2017;197:e1097.","journal-title":"J Urol"},{"key":"5127_CR18","first-page":"e1104","volume":"197","author":"AL Ackerman","year":"2017","unstructured":"Ackerman AL, Tang J, Eilber K, et al. MP82-18 shared alterations in urinary bacterial communities in patients with interstitial cystitis and overactive bladder. J Urol. 2017;197:e1104.","journal-title":"J Urol"},{"key":"5127_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5213\/inj.1938244.122","volume":"24","author":"HG Pohl","year":"2020","unstructured":"Pohl HG, Groah SL, Perez-Losada M, et al. The urine microbiome of healthy men and women differs by urine collection method. Int Neurourol J. 2020;24:41.","journal-title":"Int Neurourol J"},{"key":"5127_CR20","doi-asserted-by":"publisher","first-page":"513305","DOI":"10.3389\/fmicb.2020.513305","volume":"11","author":"G Dubourg","year":"2020","unstructured":"Dubourg G, Morand A, Mekhalif F, et al. Deciphering the urinary microbiota repertoire by culturomics reveals mostly anaerobic bacteria from the gut. Front Microbiol. 2020;11:513305.","journal-title":"Front Microbiol"},{"key":"5127_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-12-800100-4.00003-9","volume":"121","author":"J Tan","year":"2014","unstructured":"Tan J, McKenzie C, Potamitis M, et al. The role of short-chain fatty acids in health and disease. Adv Immunol. 2014;121:91.","journal-title":"Adv Immunol"},{"key":"5127_CR22","doi-asserted-by":"publisher","first-page":"727.e1","DOI":"10.1016\/j.ajog.2020.08.006","volume":"223","author":"K Thomas-White","year":"2020","unstructured":"Thomas-White K, Taege S, Limeira R, et al. Vaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms. Am J Obstet Gynecol. 2020;223:727.e1.","journal-title":"Am J Obstet Gynecol"},{"key":"5127_CR23","unstructured":"Veit-Rubin N, Mahboobani KS, Cartwright R et al. Relationship between the urinary, urothelial and vaginal microbiome in overactive bladder: https:\/\/www.ics.org\/2018\/abstract\/1. Accessed\u00a0 28 Aug 2021"},{"key":"5127_CR24","doi-asserted-by":"publisher","first-page":"e00675-18","DOI":"10.1128\/JCM.00675-18","volume":"57","author":"A Morand","year":"2019","unstructured":"Morand A, Cornu F, Dufour J-C et al. Human bacterial repertoire of the urinary tract: a potential paradigm shift. J Clin Microbiol. 2019;57:e00675-18.","journal-title":"J Clin Microbiol"},{"key":"5127_CR25","doi-asserted-by":"publisher","first-page":"e22035","DOI":"10.1097\/MD.0000000000022035","volume":"99","author":"LJ Xue","year":"2020","unstructured":"Xue LJ, Yang XZ, Tong Q, et al. Fecal microbiota transplantation therapy for Parkinson's disease: a preliminary study. Medicine (Baltimore). 2020;99:e22035.","journal-title":"Medicine (Baltimore)"},{"key":"5127_CR26","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/00365521.2021.1899277","volume":"56","author":"M Madsen","year":"2021","unstructured":"Madsen M, Kimer N, Bendtsen F, et al. Fecal microbiota transplantation in hepatic encephalopathy: a systematic review. Scand J Gastroenterol. 2021;56:560.","journal-title":"Scand J Gastroenterol"},{"key":"5127_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12866-019-1689-y","volume":"19","author":"OV Goloshchapov","year":"2019","unstructured":"Goloshchapov OV, Olekhnovich EI, Sidorenko SV, et al. Long-term impact of fecal transplantation in healthy volunteers. BMC Microbiol. 2019;19:312.","journal-title":"BMC Microbiol"},{"key":"5127_CR28","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/cid\/cix618","volume":"65","author":"R Tariq","year":"2017","unstructured":"Tariq R, Pardi DS, Tosh PK, et al. Fecal microbiota transplantation for recurrent Clostridium difficile infection reduces recurrent urinary tract infection frequency. Clin Infect Dis. 2017;65:1745.","journal-title":"Clin Infect Dis"},{"key":"5127_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12915-017-0366-6","volume":"15","author":"M Ballenghien","year":"2017","unstructured":"Ballenghien M, Faivre N, Galtier N. Patterns of cross-contamination in a multispecies population genomic project: detection, quantification, impact, and solutions. BMC Biol. 2017;15:25.","journal-title":"BMC Biol"},{"key":"5127_CR30","doi-asserted-by":"publisher","first-page":"e00475-20","DOI":"10.1128\/mBio.00475-20","volume":"11","author":"TK Price","year":"2020","unstructured":"Price TK, Wolff B, Halverson T, et al. Temporal dynamics of the adult female lower urinary tract microbiota. mBio. 2020;11:e00475-20.","journal-title":"mBio"},{"key":"5127_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/nau.20798","volume":"29","author":"BT Haylen","year":"2010","unstructured":"Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4.","journal-title":"Neurourol Urodyn"},{"key":"5127_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0090-4295(02)01784-3","volume":"60","author":"AJ Wein","year":"2002","unstructured":"Wein AJ, Rovner ES. Definition and epidemiology of overactive bladder. Urology. 2002;60:7.","journal-title":"Urology"},{"key":"5127_CR33","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1016\/S1569-9056(19)30077-6","volume":"18","author":"S Ugarcina Perovic","year":"2019","unstructured":"Ugarcina Perovic S, Ksiezarek M, Rocha J, et al. Time to change microbiological approach to overactive bladder. Eur Urol Suppl. 2019;18:e103.","journal-title":"Eur Urol Suppl"},{"key":"5127_CR34","unstructured":"Price T. A comparison of the female and male urinary microbiota in patients with and without lower urinary tract symptoms. 2017. 39th Annual American Urogynecologic Society (AUGS) Meeting, Providence, RI, USA."}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-022-05127-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-022-05127-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-022-05127-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T14:06:13Z","timestamp":1652969173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-022-05127-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["5127"],"URL":"https:\/\/doi.org\/10.1007\/s00192-022-05127-3","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]},"assertion":[{"value":"19 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Christina Sze: none; Mariel Pressler: none; John Richard Lee: holds patent US-2020-0048713-A1 entitled \u201cMethods of Detecting Cell-Free DNA in Biological Samples\u201d and receives research support under an investigator-initiated research grant from BioFire Diagnostics, LLC; Bilal Chughtai: consultant for Allergan and Boston Scientific.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}